The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
Open accessAbstract
An elevated level of fibroblast growth factor-23 (FGF-23) is the earliest abnormality of mineral metabolism in CKD. High FGF-23 levels promote left ventricular hypertrophy but not coronary artery calcification. We used survival analysis to determine whether elevated FGF-23 is associated with greater risk of adjudicated congestive heart failure (CHF) and atherosclerotic events (myocardial infarction, stroke, and peripheral vascular disease) in a prospective cohort of 3860 participants with CKD stages 2-4 (baseline estimated GFR [eGFR], 44±15 ml/min per 1.73 m(2)). During a median follow-up of 3.7 years, 360 participants were hospitalized for CHF (27 events/1000 person-years) and 287 had an atherosclerotic event (22 events/1000 person-years). After adjustment for demographic characteristics, kidney function, traditional cardiovascular risk factors, and medications, higher FGF-23 was independently associated with graded risk of CHF (hazard ratio [HR], 1.45 per doubling [95% confidence interval (CI), 1.28 to 1.65]; HR for highest versus lowest quartile, 2.98 [95% CI, 1.97 to 4.52]) and atherosclerotic events (HR per doubling, 1.24 [95% CI, 1.09 to 1.40]; HR for highest versus lowest quartile, 1.76 [95% CI, 1.20 to 2.59]). Elevated FGF-23 was associated more strongly with CHF than with atherosclerotic events (P=0.02), and uniformly was associated with greater risk of CHF events across subgroups stratified by eGFR, proteinuria, prior heart disease, diabetes, BP control, anemia, sodium intake, income, fat-free mass, left ventricular mass index, and ejection fraction. Thus, higher FGF-23 is independently associated with greater risk of cardiovascular events, particularly CHF, in patients with CKD stages 2-4.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Self-citationChronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Self-citationPrevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895 · cited 1×
“Sensitivity Analyses We performed the following sensitivity analyses: (1) analyses re-”
MethodSelf-citationCorrection of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Self-citationFibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Self-citationIsakova, T., on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, Wahl, P., Vargas, G. S., Gutiérrez, O. M., Scialla, J., Xie, H., Appleby, D., Nessel, L., Bellovich, K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.47 · Cited by 1,266
Self-citationde Lemos, J. A., Drazner, M. H., Omland, T., Ayers, C. R., Khera, A., Rohatgi, A., Hashim, I., Berry, J. D., Das, S. R., Morrow, D. A., et al. (2010) · JAMA · doi:10.1001/jama.2010.1768 · Cited by 1,102
Multiple Imputation of Missing Values: Update of Ice
Royston, P. (2005) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0500500404 · Cited by 1,041
Isakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,020
Self-citationKlotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
Hu, M. C., Shi, M., Zhang, J., Quiñones, H., Griffith, C., Kuro-o, M., & Moe, O. W. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121311 · Cited by 926
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 837
Self-citationSaunders, J. T., Nambi, V., de Lemos, J. A., Chambless, L. E., Virani, S. S., Boerwinkle, E., Hoogeveen, R. C., Liu, X., Astor, B. C., Mosley, T. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.005264 · Cited by 755
Cardiac Troponin and Outcome in Acute Heart Failure
Peacock, W. F., De Marco, T., Fonarow, G. C., Diercks, D., Wynne, J., Apple, F. S., & Wu, A. H. B. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706824 · Cited by 730
Tonelli, M., Muntner, P., Lloyd, A., Manns, B. J., Klarenbach, S., Pannu, N., James, M. T., & Hemmelgarn, B. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60572-8 · Cited by 718
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Cizman, B., Daugirdas, J., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 659
Self-citationLash, J. P., Go, A. S., Appel, L. J., He, J., Ojo, A., Rahman, M., Townsend, R. R., Xie, D., Cifelli, D., Cohan, J., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00070109 · Cited by 619
Self-citationVascular Calcification: The Killer of Patients with Chronic Kidney Disease
Mizobuchi, M., Towler, D., & Slatopolsky, E. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070692 · Cited by 542
Go, A. S., Yang, J., Ackerson, L. M., Lepper, K., Robbins, S., Massie, B. M., & Shlipak, M. G. (2006) · Circulation · doi:10.1161/circulationaha.105.577577 · Cited by 515
Self-citationUnited States Renal Data System (USRDS).
Agodoa, L. (2000) · PubMed · Cited by 490
Lim, K., Lu, T.-S., Molostvov, G., Lee, C., Lam, F. T., Zehnder, D., & Hsiao, L.-L. (2012) · Circulation · doi:10.1161/circulationaha.111.053405 · Cited by 461
Kottgen, A., Russell, S. D., Loehr, L. R., Crainiceanu, C. M., Rosamond, W. D., Chang, P. P., Chambless, L. E., & Coresh, J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101159 · Cited by 461
Parker, B. D., Schurgers, L. J., Brandenburg, V. M., Christenson, R. H., Vermeer, C., Ketteler, M., Shlipak, M. G., Whooley, M. A., & Ix, J. H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-10-201005180-00004 · Cited by 457
FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
Kendrick, J., Cheung, A. K., Kaufman, J. S., Greene, T., Roberts, W. L., Smits, G., & Chonchol, M. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121224 · Cited by 448
Prevalence and Determinants of Troponin T Elevation in the General Population
Wallace, T. W., Abdullah, S. M., Drazner, M. H., Das, S. R., Khera, A., McGuire, D. K., Wians, F., Sabatine, M. S., Morrow, D. A., & de Lemos, J. A. (2006) · Circulation · doi:10.1161/circulationaha.105.609974 · Cited by 434
Update on fibroblast growth factor 23 in chronic kidney disease
Wolf, M. (2012) · Kidney International · doi:10.1038/ki.2012.176 · Cited by 391
Self-citationMirza, M. A. I., Larsson, A., Melhus, H., Lind, L., & Larsson, T. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.013 · Cited by 341
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
Scialla, J. J., Lau, W. L., Reilly, M. P., Isakova, T., Yang, H.-Y., Crouthamel, M. H., Chavkin, N. W., Rahman, M., Wahl, P., Amaral, A. P., et al. (2013) · Kidney International · doi:10.1038/ki.2013.3 · Cited by 333
Self-citationIx, J. H., Katz, R., Kestenbaum, B. R., de Boer, I. H., Chonchol, M., Mukamal, K. J., Rifkin, D., Siscovick, D. S., Sarnak, M. J., & Shlipak, M. G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.040 · Cited by 324
Left Ventricular Hypertrophy in the Renal Patient
MIDDLETON, R. J., PARFREY, P. S., & FOLEY, R. N. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1251079 · Cited by 294
Fibroblast Growth Factor 23 and Inflammation in CKD
Munoz Mendoza, J., Isakova, T., Ricardo, A. C., Xie, H., Navaneethan, S. D., Anderson, A. H., Bazzano, L. A., Xie, D., Kretzler, M., Nessel, L., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13281211 · Cited by 267
Self-citationSeiler, S., Reichart, B., Roth, D., Seibert, E., Fliser, D., & Heine, G. H. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq309 · Cited by 198
The association between congestive heart failure and chronic renal disease
Silverberg, D., Wexler, D., Blum, M., Schwartz, D., & Iaina, A. (2004) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200403000-00004 · Cited by 177
Norris, K. C., Bourgoigne, J., Gassman, J., Hebert, L. A., Middleton, J. P., Phillips, R. A., Randall, O. S., Rostand, S. G., Sherer, S., Toto, R. D., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.08.004 · Cited by 163
Ärnlöv, J., Carlsson, A. C., Sundström, J., Ingelsson, E., Larsson, A. O., Lind, L., & Larsson, T. E. (2012) · Kidney International · doi:10.1038/ki.2012.327 · Cited by 163
Gutiérrez, O. M., Wolf, M., & Taylor, E. N. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02740311 · Cited by 161
Self-citationPostprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKD
Isakova, T., Gutierrez, O., Shah, A., Castaldo, L., Holmes, J., Lee, H., & Wolf, M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060673 · Cited by 160
Self-citationSeiler, S., Cremers, B., Rebling, N. M., Hornof, F., Jeken, J., Kersting, S., Steimle, C., Ege, P., Fehrenz, M., Rogacev, K. S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr215 · Cited by 148
Taylor, E. N., Rimm, E. B., Stampfer, M. J., & Curhan, G. C. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.02.012 · Cited by 107
Mineral Metabolites and CKD Progression in African Americans
Scialla, J. J., Astor, B. C., Isakova, T., Xie, H., Appel, L. J., & Wolf, M. S. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070713 · Cited by 107
Self-citationChronic Kidney Disease and the Risk of Heart Failure in Men
Dhingra, R., Gaziano, J. M., & Djoussé, L. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.899070 · Cited by 87
Nakano, C., Hamano, T., Fujii, N., Obi, Y., Matsui, I., Tomida, K., Mikami, S., Inoue, K., Shimomura, A., Nagasawa, Y., et al. (2012) · Bone · doi:10.1016/j.bone.2012.02.634 · Cited by 81
Self-citationInorganic phosphate and FGF‐23 predict outcome in stable systolic heart failure
Plischke, M., Neuhold, S., Adlbrecht, C., Bielesz, B. O., Shayganfar, S., Bieglmayer, C., Szekeres, T., Hörl, W. H., Strunk, G., Vavken, P., et al. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02631.x · Cited by 79
Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis
Seeherunvong, W., Abitbol, C. L., Chandar, J. J., Rusconi, P. G., Zilleruelo, G. E., & Freundlich, M. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2224-7 · Cited by 68
Smith, K., deFilippi, C. R., Isakova, T., Gutiérrez, O. M., Laliberte, K. A., Seliger, S. L., Kelley, W. E., Duh, S., Hise, M. K., Christenson, R. H., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.06.022 · Cited by 45
Self-citation
Cited by
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease
Matsushita, K., Ballew, S. H., Wang, A. Y.-M., Kalyesubula, R., Schaeffner, E., & Agarwal, R. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00616-6 · Cited by 670
Zoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
Block, G. A., Bushinsky, D. A., Cheng, S., Cunningham, J., Dehmel, B., Drueke, T. B., Ketteler, M., Kewalramani, R., Martin, K. J., Moe, S. M., et al. (2017) · JAMA · doi:10.1001/jama.2016.19468 · Cited by 317
The role of epigenetics in renal ageing
Shiels, P. G., McGuinness, D., Eriksson, M., Kooman, J. P., & Stenvinkel, P. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.78 · Cited by 114
Dussold, C., Gerber, C., White, S., Wang, X., Qi, L., Francis, C., Capella, M., Courbon, G., Wang, J., Li, C., et al. (2019) · Bone Research · doi:10.1038/s41413-019-0051-1 · Cited by 96
Self-citation
Metadata
- Authors
- Scialla, J. J., Xie, H., Rahman, M., Anderson, A. H., Isakova, T., Ojo, A., Zhang, X., Nessel, L., Hamano, T., Grunwald, J. E., Raj, D. S., Yang, W., He, J., Lash, J. P., Go, A. S., Kusek, J. W., Feldman, H., & Wolf, M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2014-02
- Volume
- 25
- Issue
- 2
- Pages
- 349-360
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2100168006
- Cited by
- 445
- References
- 47
- FWCI
- 24.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.